Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
PaperCitations, authors & open-access status
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 706 citations, 2019 year and closed oa status.
706
Citations
2019
Year
closed
OA Status